Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection remains the only curative treatment. However, fewer than 20% of patients are candidates for surgery at the time of presentation....

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Blázquez, Ariadna, Jiménez-Luna, Cristina, Díaz, Caridad, Martínez-Galán, Joaquina, Prados, Jose, Vicente, Francisca, Melguizo, Consolación, Genilloud, Olga, Pérez del Palacio, José, Caba, Octavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225994/
https://www.ncbi.nlm.nih.gov/pubmed/32325731
http://dx.doi.org/10.3390/cancers12041002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225994/
https://www.ncbi.nlm.nih.gov/pubmed/32325731
http://dx.doi.org/10.3390/cancers12041002

Ejemplares similares